Accuray Incorporated logo

Accuray Incorporated (XEJ)

Market Closed
1 Dec, 07:09
XBER XBER
0. 94
+0.05
+5.65%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
0.88
Previous Close
Day Range
0.94 0.94
Year Range
0.8 2.52
Want to track XEJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 58 days

Summary

XEJ closed Monday higher at €0.94, an increase of 5.65% from Friday's close, completing a monthly increase of 0% or €0. Over the past 12 months, XEJ stock lost -50.53%.
XEJ is not paying dividends to its shareholders.
The last earnings report, released on Nov 05, 2025, exceeded the consensus estimates by 0.05%. On average, the company has surpassed earnings expectations by 0.02%, based on the last three reports. The next scheduled earnings report is due on Feb 03, 2026.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

XEJ Chart

Accuray Incorporated (ARAY) Q1 2026 Earnings Call Transcript

Accuray Incorporated (ARAY) Q1 2026 Earnings Call Transcript

Accuray Incorporated ( ARAY ) Q1 2026 Earnings Call November 5, 2025 4:30 PM EST Company Participants Stephen Monroe Stephen LaNeve - President, CEO & Director Ali Pervaiz - Senior VP & CFO Conference Call Participants Marie Thibault - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to the Accuray First Quarter Fiscal 2026 Financial Results Conference Call. [Operator Instructions].

Seekingalpha | 1 month ago
Accuray Incorporated (ARAY) Shareholder/Analyst Call Transcript

Accuray Incorporated (ARAY) Shareholder/Analyst Call Transcript

Accuray Incorporated (NASDAQ:ARAY ) Shareholder/Analyst Call September 29, 2025 4:30 PM EDT Company Participants Suzanne Winter - President, CEO & Director Mu Lee - Senior Vice President of Research & Product Development Seth Blacksburg - Senior VP & Chief Medical Officer Conference Call Participants Shalom Kalnicki Jonathan Haas Giuseppe Sasso John Kresl Presentation Suzanne Winter President, CEO & Director Good afternoon, everyone, and welcome to Accuray's Analyst briefing. We're coming to you from the ASTRO conference in San Francisco for 2025.

Seekingalpha | 2 months ago
Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y

Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y

ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.

Zacks | 3 months ago

Accuray Incorporated (XEJ) FAQ

What is the stock price today?

The current price is €0.94.

On which exchange is it traded?

Accuray Incorporated is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is XEJ.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 03, 2026.

Has Accuray Incorporated ever had a stock split?

No, there has never been a stock split.

Accuray Incorporated Profile

- Industry
- Sector
Stephen R. LaNeve MBA CEO
XBER Exchange
US0043971052 ISIN
US Country
987 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Accuray Incorporated is a leading innovator in the field of precision radiation oncology, providing advanced radiosurgery and radiation therapy systems worldwide. Founded in 1990 and based in Madison, Wisconsin, the company's pioneering solutions are designed to enhance cancer treatment by targeting tumors with high precision. Accuray’s global reach extends across the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the rest of the Asia Pacific region. The company is committed to improving patient outcomes by offering cutting-edge technology for the treatment of primary and metastatic tumors outside the brain, among other applications. In addition to developing and manufacturing its products, Accuray Incorporated offers a comprehensive range of support services including post-contract customer support, installation, training, and professional services to ensure the effective use and maintenance of its systems.

Products and Services

  • CyberKnife System

This innovative robotic stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) system is at the forefront of Accuray’s offerings. The CyberKnife System is designed for the treatment of primary and metastatic tumors located outside the brain. It is particularly effective for tumors on or near the spine and in regions such as the breast, kidney, liver, lung, pancreas, and prostate. Utilizing robotic technology, the system delivers highly precise treatment, minimizing damage to surrounding healthy tissue.

  • TomoTherapy System, including the Radixact System

The TomoTherapy and Radixact Systems represent a significant advancement in the delivery of radiation therapy, enabling clinicians to perform ultra-precise treatments for a wide range of cancers. These systems feature integrated radiation treatment planning, delivery, and data management capabilities. The high level of precision and efficiency allows for treating approximately 50 patients per day, making it a pivotal tool in high-volume treatment centers.

  • iDMS Data Management System

Accuray’s iDMS Data Management System is designed to enhance the efficiency of treatment planning and delivery by providing a fully integrated suite for managing patient data and treatment plans. This system streamlines the workflow, facilitating a more seamless operation from planning through treatment.

  • Accuray Precision Treatment Planning System

The Accuray Precision Treatment Planning System is tailored to support the detailed and complex planning required for delivering precise radiation therapy. By offering sophisticated data management and planning tools, this system aids clinicians in creating optimized treatment strategies for their patients.

  • Professional Services

In addition to its pioneering technology, Accuray Incorporated provides a comprehensive suite of professional services. These include post-contract customer support, which ensures that all systems are maintained to the highest standards, as well as installation and training services. Through these offerings, Accuray empowers healthcare providers to maximize the benefits of its systems for patients, thereby enhancing treatment outcomes and operational efficiency.

Contact Information

Address: 1240 Deming Way
Phone: 608 824 2800